Titan Pharmaceuticals
TTNP
#10473
Rank
S$7.84 M
Marketcap
S$5.89
Share price
-3.76%
Change (1 day)
10.89%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -S$3.69 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$6.02 Million, an increase over its 2023 earnings that were of -S$7.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$3.69 Million-38.74%
2024 -S$6.02 Million-15.5%
2023 -S$7.13 Million-45.43%
2022 -S$13.05 Million16.29%
2021 -S$11.23 Million-907.36%
2020 S$1.38 M-106.6%
2019 -S$21.05 Million82.4%
2018 -S$11.54 Million-36.93%
2017 -S$18.3 Million-378.62%
2016 S$6.56 M-145.53%
2015 -S$14.43 Million369.37%
2014 -S$3.08 Million-125.9%
2013 S$11.86 M-177.74%
2012 -S$15.26 Million13.59%
2011 -S$13.44 Million74.37%
2010 -S$7.71 Million3.61%
2009 -S$7.44 Million
2007 -S$23.57 Million12.08%
2006 -S$21.03 Million-28.65%
2005 -S$29.48 Million-10.03%
2004 -S$32.76 Million-6.08%
2003 -S$34.88 Million-14.76%
2002 -S$40.92 Million32.52%
2001 -S$30.88 Million27.55%
2000 -S$24.21 Million62.5%
1999 -S$14.9 Million4.04%
1998 -S$14.33 Million49.33%
1997 -S$9.59 Million-27.88%
1996 -S$13.3 Million13.04%
1995 -S$11.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.42 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.90 B-583,059.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-S$0.16 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$33.42 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.35 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA